Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer

Fig. 2

Clinical relevance and pathways analysis for TMB. a The best cut-off value of TMB was 6.4 computed by X-title. b KM curves of overall survival of high and low TMB groups. c-f The correlation between TMB scores and clinical stage, T stage, pathology grade and smoking level. g The top 4 results of GSEA between high and low TMB patients

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us